CORCORAN E THOMAS
Known title: DirectorCIK: 0001191763
CORCORAN E THOMAS's purchase track record
How the stock did after each of CORCORAN E THOMAS's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 4 since August 30, 2021
Stock higher 6 months later
67%
3 months: 75%
Median 6-month return
+20.8%
3 months: +16.0%
Beat the S&P 500
67%
median +15.0% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/29/2026 | PAHC | $318K | +22.8% | pending | — |
| 2/24/2025 | PAHC | $111K | +11.1% | +45.8% | +7.6% |
| 9/4/2024 | PAHC | $100K | +20.9% | +20.8% | +5.8% |
| 8/30/2021 | PAHC | $118K | -11.5% | -9.6% | -3.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PAHC | ▲ Buy | Open Market | 10,000 | $318K | 5/29/2026 | View on chart |
| PAHC | ▲ Buy | Open Market | 5,000 | $111K | 2/24/2025 | View on chart |
| PAHC | ▲ Buy | Open Market | 5,000 | $100K | 9/4/2024 | View on chart |
| PAHC | ▲ Buy | Open Market | 5,000 | $118K | 8/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Phibro Animal Health (PAHC) Draws Attention Amid Small-Cap Review
Phibro Animal Health (PAHC) is currently the focus of market attention, with recent articles discussing whether it is the right time to hold the stock. The company is also highlighted in a list of small-cap stocks showing warning signs. This news provides context for the stock's current position within its 52-week range, which spans from $28.25 to $60.08.
Phibro Animal Health (PAHC) Draws Attention Amid Small-Cap Review. Phibro Animal Health (PAHC) is currently the focus of market attention, with recent articles discussing whether it is the right time to hold the stock. The company is also highlighted in a list of small-cap stocks showing warning signs. This news provides context for the stock's current position within its 52-week range, which spans from $28.25 to $60.08.